LASA SUPERGENERICS
Back to Balance Sheet
|
LASA SUPERGENERICS Last 5 Year Total Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹151 Cr | ₹164 Cr | ₹209 Cr | ₹208 Cr | ₹229 Cr |
What is the latest Total Liabilities ratio of LASA SUPERGENERICS ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹151 Cr |
Mar2023 | ₹164 Cr |
Mar2022 | ₹209 Cr |
Mar2021 | ₹208 Cr |
Mar2020 | ₹229 Cr |
How is Total Liabilities of LASA SUPERGENERICS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹151 Cr | -7.93 | |
Mar2023 | ₹164 Cr | -21.66 | |
Mar2022 | ₹209 Cr | 0.63 | |
Mar2021 | ₹208 Cr | -9.16 | |
Mar2020 | ₹229 Cr | - |
Compare Total Liabilities of peers of LASA SUPERGENERICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LASA SUPERGENERICS | ₹41.4 Cr | -10.9% | -22.6% | -73.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,466.0 Cr | -3% | -6.8% | -11.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,423.0 Cr | -0.5% | -8.4% | 25.1% | Stock Analytics | |
CIPLA | ₹128,405.0 Cr | -0.2% | 1% | -1.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,448.0 Cr | -3.4% | -5.6% | 6.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,408.0 Cr | -1.1% | -2.9% | -9.5% | Stock Analytics |
LASA SUPERGENERICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LASA SUPERGENERICS | -10.9% |
-22.6% |
-73.1% |
SENSEX | -2.7% |
-1.3% |
-2.3% |
You may also like the below Video Courses